Literature DB >> 24125020

Varicella zoster virus in the temporal artery of a patient with giant cell arteritis.

Maria A Nagel1, Nelly Khmeleva, Philip J Boyer, Alexander Choe, Robert Bert, Don Gilden.   

Abstract

We recently detected varicella zoster virus (VZV) in the temporal arteries (TA) of 5/24 patients with clinically suspect giant cell arteritis (GCA) whose TAs were GCA-negative pathologically; in those GCA-negative, VZV+TAs, virus antigen predominated in the arterial adventitia, but without medial necrosis and multinucleated giant cells. During our continuing search for VZV antigen in GCA-negative TAs, in the TA of one subject, we found abundant VZV antigen, as well as VZV DNA, in multiple regions (skip areas) of the TA spanning 350 μm, as well as in skeletal muscle adjacent to the infected TA. Additional pathological analysis of sections adjacent to those containing viral antigen revealed inflammation involving the arterial media and abundant multinucleated giant cells characteristic of GCA. Detection of VZV in areas of the TA with pathological features of GCA warrants further correlative pathological-virological analysis of VZV in GCA.
© 2013.

Entities:  

Keywords:  Giant cell arteritis; Stroke; Temporal arteritis; Temporal artery; Varicella zoster virus; Vasculopathy

Mesh:

Substances:

Year:  2013        PMID: 24125020      PMCID: PMC3848200          DOI: 10.1016/j.jns.2013.09.034

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia.

Authors:  Randall J Cohrs; Donald H Gilden
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

2.  Comparison of glutamate-evoked pain between the temporalis and masseter muscles in men and women.

Authors:  Eduardo E Castrillon; Brian E Cairns; Kelun Wang; Lars Arendt-Nielsen; Peter Svensson
Journal:  Pain       Date:  2012-02-14       Impact factor: 6.961

3.  Sensitivity of rat temporalis muscle afferent fibers to peripheral N-methyl-D-aspartate receptor activation.

Authors:  X D Dong; M K Mann; B J Sessle; L Arendt-Nielsen; P Svensson; B E Cairns
Journal:  Neuroscience       Date:  2006-05-22       Impact factor: 3.590

4.  Skip lesions in temporal arteritis.

Authors:  R G Klein; R J Campbell; G G Hunder; J A Carney
Journal:  Mayo Clin Proc       Date:  1976-08       Impact factor: 7.616

5.  The peptidergic innervation of the human superficial temporal artery: immunohistochemistry, ultrastructure, and vasomotility.

Authors:  I J Olesen; S Gulbenkian; A Valença; J L Antunes; J Wharton; J M Polak; L Edvinsson
Journal:  Peptides       Date:  1995       Impact factor: 3.750

6.  Multifocal VZV vasculopathy with temporal artery infection mimics giant cell arteritis.

Authors:  Maria A Nagel; Jeffrey L Bennett; Nelly Khmeleva; Alexander Choe; April Rempel; Philip J Boyer; Don Gilden
Journal:  Neurology       Date:  2013-05-01       Impact factor: 9.910

  6 in total
  24 in total

Review 1.  Pathogenesis of varicelloviruses in primates.

Authors:  Werner J D Ouwendijk; Georges M G M Verjans
Journal:  J Pathol       Date:  2015-01       Impact factor: 7.996

Review 2.  Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.

Authors:  Eleni I Kampylafka; Harry Alexopoulos; Marinos C Dalakas; Athanasios G Tzioufas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

3.  Editorial commentary: varicella zoster virus infection: generally benign in kids, bad in grown-ups.

Authors:  Maria Nagel; Don Gilden
Journal:  Clin Infect Dis       Date:  2014-04-02       Impact factor: 9.079

4.  Association of varicella zoster virus with giant cell arteritis.

Authors:  Don Gilden
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2014-06-03

Review 5.  Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis.

Authors:  Maria A Nagel; Dallas Jones; Ann Wyborny
Journal:  J Neuroimmunol       Date:  2017-03-18       Impact factor: 3.478

Review 6.  Update on the management of giant cell arteritis.

Authors:  Janet Roberts; Alison Clifford
Journal:  Ther Adv Chronic Dis       Date:  2017-03-28       Impact factor: 5.091

Review 7.  Varicella zoster virus and giant cell arteritis.

Authors:  Don Gilden; Maria A Nagel
Journal:  Curr Opin Infect Dis       Date:  2016-06       Impact factor: 4.915

8.  Biopsy-negative, varicella zoster virus (VZV)-positive giant cell arteritis, zoster, VZV encephalitis and ischemic optic neuropathy, all in one.

Authors:  Tiago Teodoro; Maria A Nagel; Ruth Geraldes; Teresa White; Ravi Mahalingam; Paulo Batista; Mary Wellish; Jose Pimentel; Nelly Khmeleva; Anna Heintzman; Luísa Albuquerque; Philip J Boyer; Alexander Choe; Rita Peralta; Don Gilden
Journal:  J Neurol Sci       Date:  2014-05-27       Impact factor: 3.181

Review 9.  Neurological complications of varicella zoster virus reactivation.

Authors:  Maria A Nagel; Don Gilden
Journal:  Curr Opin Neurol       Date:  2014-06       Impact factor: 5.710

10.  Successful Antiviral Treatment of Giant Cell Arteritis and Takayasu Arteritis.

Authors:  Don Gilden; Teresa M White; Lidia Nagae; William H Gurdin; Philip J Boyer; Maria A Nagel
Journal:  JAMA Neurol       Date:  2015-08       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.